Naoko Takebe to Metabolic Clearance Rate
This is a "connection" page, showing publications Naoko Takebe has written about Metabolic Clearance Rate.
Connection Strength
0.229
-
A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Br J Clin Pharmacol. 2019 11; 85(11):2499-2511.
Score: 0.170
-
The effect of liver dysfunction on the pharmacokinetic disposition of belinostat and its five metabolites in patients with advanced cancers. Cancer Chemother Pharmacol. 2024 Aug; 94(2):157-167.
Score: 0.058